PELI1 and Insulin resistance: These results suggest that in addition to insulin resistance-mediated inhibition of vasodilator signaling, a reduced Pellino-1 expression, due to inhibition of VEGF signaling pathway by sunitinib, may also involve in attenuation of AKT/eNOS activation.